RGD Reference Report - Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat.

Authors: Fillmann, H  Kretzmann, NA  San-Miguel, B  Llesuy, S  Marroni, N  Gonzalez-Gallego, J  Tunon, MJ 
Citation: Fillmann H, etal., Toxicology. 2007 Jul 17;236(3):217-26. Epub 2007 Apr 27.
RGD ID: 2298659
Pubmed: PMID:17543437   (View Abstract at PubMed)
DOI: DOI:10.1016/j.tox.2007.04.012   (Journal Full-text)

We investigated the effects of glutamine on markers of oxidative stress, nuclear factor kappaB (NF-kappaB) activation, and pro-inflammatory mediators in a rat model of experimental colitis induced by intracolonic administration of 7% acetic acid. Glutamine (25 mg/kg) was given by rectal route 48 and 24h before acetic acid instillation. Glutamine significantly reduced gross damage and histopathological scores, and partially prevented the decrease of anal pressure observed in the animals receiving acetic acid. Increases in the cytosolic concentration of TBARS and hydroperoxide-initiated chemiluminescence were significantly prevented in glutamine-treated animals. Acetic acid instillation induced a marked increase of the NF-kappaB p65 subunit expression in the nucleus and resulted in significant changes in the cytosolic protein level of IkappaB kinases (IKKalpha and IKKbeta) and the non-phosphorylated form of the inhibitor IkappaBalpha. Protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) were significantly increased. All these effects were partially prevented by administration of glutamine. It is concluded that the anti-inflammatory activity of glutamine in a rat model of acetic acid-induced colitis may be mediated, at least in part, by inhibition of the expression of certain pro-inflammatory mediators which are regulated by the oxidative stress-sensitive NF-kappaB signalling pathway.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
CHUKHumancolitis treatmentISOChuk (Rattus norvegicus) RGD 
ChukRatcolitis treatmentIEP  RGD 
ChukMousecolitis treatmentISOChuk (Rattus norvegicus) RGD 
IKBKBHumancolitis treatmentISOIkbkb (Rattus norvegicus) RGD 
IkbkbRatcolitis treatmentIEP  RGD 
IkbkbMousecolitis treatmentISOIkbkb (Rattus norvegicus) RGD 
PTGS2Humancolitis treatmentISOPtgs2 (Rattus norvegicus) RGD 
Ptgs2Ratcolitis treatmentIEP  RGD 
Ptgs2Mousecolitis treatmentISOPtgs2 (Rattus norvegicus) RGD 

Gene Ontology Annotations    Click to see Annotation Detail View

Biological Process

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
ChukRatresponse to acetate  IEP  RGD 
ChukRatresponse to amino acid  IEP  RGD 

Objects Annotated

Genes (Rattus norvegicus)
Chuk  (component of inhibitor of nuclear factor kappa B kinase complex)
Ikbkb  (inhibitor of nuclear factor kappa B kinase subunit beta)
Ptgs2  (prostaglandin-endoperoxide synthase 2)

Genes (Mus musculus)
Chuk  (conserved helix-loop-helix ubiquitous kinase)
Ikbkb  (inhibitor of kappaB kinase beta)
Ptgs2  (prostaglandin-endoperoxide synthase 2)

Genes (Homo sapiens)
CHUK  (component of inhibitor of nuclear factor kappa B kinase complex)
IKBKB  (inhibitor of nuclear factor kappa B kinase subunit beta)
PTGS2  (prostaglandin-endoperoxide synthase 2)


Additional Information